Rubric Capital Management LP
- SEC CIK
- 0001687509
- Latest filing
- Aug 14, 2026
The latest 13F from Rubric Capital Management LP covers Q2 2026 (filed Aug 14, 2026): 87 long positions worth $10.9B. The top 10 holdings make up 46.4% of the portfolio, and the largest is Talen Energy Corp (TLN) at 12.7%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Full comparisonShare counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 18
- Est. +$965.6M
- Added
- 35
- Est. +$1.53B
- Reduced
- 10
- Est. −$269.7M
- Sold out
- 13
- Est. −$631.6M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $10.9B
- +$2.74B (+33.5%) vs. prior quarter
- Positions
- 87
- +5 vs. prior quarter
- Top 10 concentration
- 46.4%
- Top 10 as share of value
- Turnover
- 9.5%
- Q2 2026, one quarter
- Average holding period
- 8.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $10.9B (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 87 | $10.9B | TLNFTAIVTRS | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 82 | $8.16B | TLNFTAIGLNG | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 76 | $8.36B | TLNFTAITEVA | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 70 | $7.45B | TLNFTAITEVA | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 63 | $6.22B | TLNTEVAFTAI | vs. Q1 2025 | SEC |
| Q1 2025 | May 14, 2025 | 65 | $5.58B | TLNTEVAGLNG | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 67 | $5.50B | TLNTEVAGLNG | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 13, 2024 | 64 | $6.11B | TLNTEVAROIV | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 13, 2024 | 67 | $3.79B | TEVAROIVVTRS | vs. Q1 2024 | SEC |
| Q1 2024 | May 10, 2024 | 68 | $3.38B | TEVAVTRSROIV | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 13, 2024 | 57 | $2.68B | ROIVTEVAVTRS | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 15, 2023Amended | 59 | $2.38B | TEVAGLNGVTRS | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 11, 2023 | 61 | $2.34B | TEVAGLNGVTRS | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 70 | $2.51B | GLNGSTNGCCJ | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 10, 2023 | 94 | $2.29B | GLNGFLRHTZ | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 87 | $1.99B | GLNGHTZFLR | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022Amended | 88 | $1.90B | GLNGHTZPLYA | vs. Q1 2022 | SEC |
| Q1 2022 | May 13, 2022 | 70 | $2.15B | HTZGLNGPLYA | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 68 | $2.12B | HTZPLYAGSM | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 55 | $1.74B | WSCGSMPLYA | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 13, 2021 | 56 | $1.58B | GLNGPLYAWSC | vs. Q1 2021 | SEC |
| Q1 2021 | May 14, 2021 | 58 | $1.68B | WSCALLYCOLL | – | SEC |
13D and 13G filings
Companies where Rubric Capital Management LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
27 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| HRTXHeron Therapeutics, Inc. | 13D/A | 15.90%30.0M shares | −1.60 ppfrom 17.50% | Feb 6, 20236 filings | Oct 17, 2025 | SEC |
| LILALiberty Latin America Ltd. | 13G | 9.85%3.75M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| MGTXMeiraGTx Holdings plc | 13G/A | 9.83%9.10M shares | +1.93 ppfrom 7.90% | Feb 13, 20262 filings | Aug 14, 2026 | SEC |
| ZYMEZymeworks Inc. | 13G/A | 9.49%7.00M shares | +1.81 ppfrom 7.68% | Nov 13, 20243 filings | May 15, 2026 | SEC |
| IARTIntegra Lifesciences Holdings Corp | 13G/A | 9.46%7.35M shares | +3.45 ppfrom 6.01% | May 14, 20252 filings | Jul 9, 2025 | SEC |
| PRTAProthena Corp Public Ltd Co | 13G/A | 9.29%5.00M shares | +2.46 ppfrom 6.83% | Feb 13, 20262 filings | May 15, 2026 | SEC |
| SDGRSchrodinger, Inc. | 13G/A | 9.28%6.00M shares | +2.81 ppfrom 6.47% | Nov 13, 20244 filings | May 15, 2026 | SEC |
| ECVTEcovyst Inc. | 13G | 9.09%10.4M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| GLNGGolar LNG Ltd | 13G/A | 8.59%8.98M shares | +1.20 ppfrom 7.39% | Feb 14, 20225 filings | May 14, 2025 | SEC |
| EPCEdgewell Personal Care Co | 13G | 8.56%4.00M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| SPRYARS Pharmaceuticals, Inc. | 13G/A | 8.06%8.00M shares | +1.79 ppfrom 6.27% | Feb 13, 20262 filings | May 15, 2026 | SEC |
| CVGWCalavo Growers Inc | 13G | 7.93%1.42M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| TLNTalen Energy Corp | 13G/A | 7.88%3.60M shares | −2.02 ppfrom 9.90% | Nov 13, 20244 filings | Nov 14, 2025 | SEC |
| EDSAEdesa Biotech, Inc. | 13G | 7.74%687.5K shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| KNSAKiniksa Pharmaceuticals International, plc | 13G/A | 7.37%3.33M shares | −1.87 ppfrom 9.24% | Feb 12, 20245 filings | Feb 13, 2026 | SEC |
| NRIXNurix Therapeutics, Inc. | 13G | 6.96%7.23M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| ENOVEnovis CORP | 13G | 6.78%3.90M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| AVOMission Produce, Inc. | 13G | 6.77%5.98M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 13G/A | 6.75%8.27M shares | – | Feb 12, 20243 filings | Feb 13, 2026 | SEC |
| ARDXArdelyx, Inc. | 13G | 6.56%16.2M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| CMPRCIMPRESS plc | 13G | 6.18%1.52M shares | New | Feb 13, 20261 filing | Feb 13, 2026 | SEC |
| OPKOpko Health, Inc. | 13G/A | 6.03%47.8M shares | – | Nov 13, 20242 filings | Jul 9, 2025 | SEC |
| BGCBGC Group, Inc. | 13G | 5.84%21.0M shares | – | Feb 10, 20234 filings | Feb 13, 2026 | SEC |
| MNKDMannkind Corp | 13G | 5.83%18.0M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| LBTYALiberty Global Ltd. | 13G | 5.74%10.0M shares | New | Feb 13, 20261 filing | Feb 13, 2026 | SEC |
Showing the 25 largest of 27 stakes.
Latest filings
184 filings on file made by Rubric Capital Management LP or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| TSATTelesat Corp | Aug 14, 20264:06 PM ET | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2026 | SEC |
| MGTXMeiraGTx Holdings plc | Aug 14, 20264:05 PM ET | 13G/A | 9.83%9.10M shares | +1.93 ppfrom 7.90% | Jun 30, 2026 | SEC |
| NRIXNurix Therapeutics, Inc. | Aug 14, 20264:05 PM ET | 13G | 6.96%7.23M shares | New | Jun 30, 2026 | SEC |
| MNKDMannkind Corp | Aug 14, 20264:04 PM ET | 13G | 5.83%18.0M shares | New | Jun 30, 2026 | SEC |
| ENOVEnovis CORP | Aug 14, 20264:04 PM ET | 13G | 6.78%3.90M shares | New | Jun 30, 2026 | SEC |
| AVOMission Produce, Inc. | Aug 14, 20264:04 PM ET | 13G | 6.77%5.98M shares | New | Jun 30, 2026 | SEC |
| ARDXArdelyx, Inc. | Aug 14, 20264:03 PM ET | 13G | 6.56%16.2M shares | New | Jun 30, 2026 | SEC |
| ZYMEZymeworks Inc. | May 15, 20264:09 PM ET | 13G/A | 9.49%7.00M shares | +1.81 ppfrom 7.68% | Mar 31, 2026 | SEC |
| SPRYARS Pharmaceuticals, Inc. | May 15, 20264:08 PM ET | 13G/A | 8.06%8.00M shares | +1.79 ppfrom 6.27% | Mar 31, 2026 | SEC |
| SDGRSchrodinger, Inc. | May 15, 20264:08 PM ET | 13G/A | 9.28%6.00M shares | +2.81 ppfrom 6.47% | Mar 31, 2026 | SEC |
| PRTAProthena Corp Public Ltd Co | May 15, 20264:07 PM ET | 13G/A | 9.29%5.00M shares | +2.46 ppfrom 6.83% | Mar 31, 2026 | SEC |
| NFENew Fortress Energy Inc. | May 15, 20264:07 PM ET | 13G/A | 0.00%0 shares | −8.89 ppfrom 8.89%Below 5% | Mar 31, 2026 | SEC |
| LILALiberty Latin America Ltd. | May 15, 20264:04 PM ET | 13G | 9.85%3.75M shares | New | Mar 31, 2026 | SEC |
| EPCEdgewell Personal Care Co | May 15, 20264:04 PM ET | 13G | 8.56%4.00M shares | New | Mar 31, 2026 | SEC |
| EDSAEdesa Biotech, Inc. | May 15, 20264:03 PM ET | 13G | 7.74%687.5K shares | New | Mar 31, 2025 | SEC |
| CVGWCalavo Growers Inc | May 15, 20264:02 PM ET | 13G | 7.93%1.42M shares | New | Mar 31, 2026 | SEC |
| ZYMEZymeworks Inc. | Feb 13, 20264:27 PM ET | 13G/A | 7.68%5.75M shares | – | Dec 31, 2025 | SEC |
| TRVITrevi Therapeutics, Inc. | Feb 13, 20264:26 PM ET | 13G/A | 2.94%3.77M shares | −4.18 ppfrom 7.12%Below 5% | Dec 31, 2025 | SEC |
| SPRYARS Pharmaceuticals, Inc. | Feb 13, 20264:24 PM ET | 13G | 6.27%6.20M shares | New | Dec 31, 2025 | SEC |
| SDGRSchrodinger, Inc. | Feb 13, 20264:23 PM ET | 13G/A | 6.47%4.17M shares | −1.38 ppfrom 7.85% | Dec 31, 2025 | SEC |